Global Peptide CDMO Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Peptide CDMO market size will reach 5,313.25 Million USD in 2025 and is projected to reach 14,030.44 Million USD by 2032, with a CAGR of 14.88% (2025-2032). Notably, the China Peptide CDMO market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A Peptide Contract Development and Manufacturing Organization (CDMO) is a specialized company that offers comprehensive services for the development, production, and manufacturing of peptides. Peptides are short chains of amino acids that play a crucial role in various biological processes and are used in a wide range of applications, including pharmaceuticals, diagnostics, and research. Peptide CDMOs work with pharmaceutical and biotechnology companies to provide expertise in peptide synthesis, process development, quality control, and large-scale manufacturing. They can assist in all stages of peptide development, from early research and development to the commercial production of peptide-based products. Peptide CDMOs play a vital role in accelerating the development of peptide-based drugs and therapies, ensuring high-quality production, and meeting the regulatory requirements of the pharmaceutical industry.
The major global suppliers of Peptide CDMO include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptide CDMO. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Peptide CDMO market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Peptide CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Peptide CDMO Include:
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Peptide CDMO Product Segment Include:
APIs and Intermediates
FDF
Peptide CDMO Product Application Include:
Commercial
Academic Research
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Peptide CDMO Industry PESTEL Analysis
Chapter 3: Global Peptide CDMO Industry Porter's Five Forces Analysis
Chapter 4: Global Peptide CDMO Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Peptide CDMO Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Peptide CDMO Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Peptide CDMO Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Peptide CDMO market size will reach 5,313.25 Million USD in 2025 and is projected to reach 14,030.44 Million USD by 2032, with a CAGR of 14.88% (2025-2032). Notably, the China Peptide CDMO market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A Peptide Contract Development and Manufacturing Organization (CDMO) is a specialized company that offers comprehensive services for the development, production, and manufacturing of peptides. Peptides are short chains of amino acids that play a crucial role in various biological processes and are used in a wide range of applications, including pharmaceuticals, diagnostics, and research. Peptide CDMOs work with pharmaceutical and biotechnology companies to provide expertise in peptide synthesis, process development, quality control, and large-scale manufacturing. They can assist in all stages of peptide development, from early research and development to the commercial production of peptide-based products. Peptide CDMOs play a vital role in accelerating the development of peptide-based drugs and therapies, ensuring high-quality production, and meeting the regulatory requirements of the pharmaceutical industry.
The major global suppliers of Peptide CDMO include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Peptide CDMO. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Peptide CDMO market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Peptide CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Peptide CDMO Include:
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
Peptide CDMO Product Segment Include:
APIs and Intermediates
FDF
Peptide CDMO Product Application Include:
Commercial
Academic Research
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Peptide CDMO Industry PESTEL Analysis
Chapter 3: Global Peptide CDMO Industry Porter's Five Forces Analysis
Chapter 4: Global Peptide CDMO Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Peptide CDMO Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Peptide CDMO Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Peptide CDMO Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Peptide CDMO Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Peptide CDMO Product by Type
- 1.2.1 APIs and Intermediates
- 1.2.2 FDF
- 1.3 Peptide CDMO Product by Application
- 1.3.1 Commercial
- 1.3.2 Academic Research
- 1.4 Global Peptide CDMO Market Size Analysis (2020-2032)
- 1.5 Peptide CDMO Market Development Status and Trends
- 1.5.1 Peptide CDMO Industry Development Status Analysis
- 1.5.2 Peptide CDMO Industry Development Trends Analysis
- 2 Peptide CDMO Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Peptide CDMO Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Peptide CDMO Market Analysis by Country
- 4.1 Global Peptide CDMO Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Peptide CDMO Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Peptide CDMO Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.5 China Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.6 France Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.14 India Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Peptide CDMO Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Peptide CDMO Market Revenue by Key Suppliers (2021-2025)
- 5.2 Peptide CDMO Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Peptide CDMO Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Peptide CDMO Market Analysis by Type
- 6.1 Global Peptide CDMO Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Peptide CDMO Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Bachem
- 7.1.1 Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Bachem Peptide CDMO Product Portfolio
- 7.1.3 Bachem Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 PolyPeptide
- 7.2.1 PolyPeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 PolyPeptide Peptide CDMO Product Portfolio
- 7.2.3 PolyPeptide Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 CordenPharma
- 7.3.1 CordenPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 CordenPharma Peptide CDMO Product Portfolio
- 7.3.3 CordenPharma Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 AmbioPharm
- 7.4.1 AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 AmbioPharm Peptide CDMO Product Portfolio
- 7.4.3 AmbioPharm Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 USV Peptides
- 7.5.1 USV Peptides Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 USV Peptides Peptide CDMO Product Portfolio
- 7.5.3 USV Peptides Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Thermofischer
- 7.6.1 Thermofischer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Thermofischer Peptide CDMO Product Portfolio
- 7.6.3 Thermofischer Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Bio Basic
- 7.7.1 Bio Basic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Bio Basic Peptide CDMO Product Portfolio
- 7.7.3 Bio Basic Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 JPT
- 7.8.1 JPT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 JPT Peptide CDMO Product Portfolio
- 7.8.3 JPT Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Genscript
- 7.9.1 Genscript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Genscript Peptide CDMO Product Portfolio
- 7.9.3 Genscript Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Xinbang Pharma
- 7.10.1 Xinbang Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Xinbang Pharma Peptide CDMO Product Portfolio
- 7.10.3 Xinbang Pharma Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 ScinoPharm
- 7.11.1 ScinoPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 ScinoPharm Peptide CDMO Product Portfolio
- 7.11.3 ScinoPharm Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 SN Biopharm
- 7.12.1 SN Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 SN Biopharm Peptide CDMO Product Portfolio
- 7.12.3 SN Biopharm Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 CBL
- 7.13.1 CBL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 CBL Peptide CDMO Product Portfolio
- 7.13.3 CBL Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Piramal Pharma
- 7.14.1 Piramal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Piramal Pharma Peptide CDMO Product Portfolio
- 7.14.3 Piramal Pharma Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 CPC Scientific
- 7.15.1 CPC Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 CPC Scientific Peptide CDMO Product Portfolio
- 7.15.3 CPC Scientific Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Peptide CDMO Industry Chain Analysis
- 8.2 Peptide CDMO Product Downstream Application Analysis
- 8.2.1 Global Peptide CDMO Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Peptide CDMO Revenue and Forecast by Application (2020-2032)
- 8.3 Peptide CDMO Typical Downstream Customers
- 8.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
